RESUMO Quadros crônico-degenerativos são prevalentes na população idosa. Estudos prévios tem correlacionado prejuízo cognitivo em idosos com hipertensão e hiperglicemia que por sua vez são doenças bastante comuns do envelhecimento na população mundial. Apesar disso ainda existem dados controversos sobre a associação entre prejuízo cognitivo e síndrome metabólica (SMet). Objetivo: Comparar o estado cognitivo de pacientes brasileiros idosos em atendimento ambulatorial com e sem SMet. Métodos: Estudo de caso-controle transversal com 49 pacientes (25 com SMet e 24 controles) que foram submetidos à avaliação geriátrica global e neuropsicológica. Os escores de habilidades cognitivas (atenção sustentada, atenção alternada, memória imediata, memória operacional, memória tardia - evocação imediata, tardia e de reconhecimento -, função executiva, praxia ideomotora, praxia visuo-construtiva, habilidade de nomeação e fluência verbal) foram comparados com dados da população saudável e a diferença entre caso e controle foi analisada usando o teste t de Student ou o teste de Mann-Whitney. Resultados: Quarenta e cinco pacientes (91.8%) foram mulheres com idade média de 73.9±5.9 anos e escolaridade média de 3.0±1.0 anos. Observou-se uma diferença significativa (p<0.01) entre os grupos com relação aos critérios da SMet. Com relação às habilidades cognitivas não houve diferença estatística entre os grupos e todos os pacientes apresentaram baixo escore cognitivo. Conclusão: Os resultados obtidos no presente estudo indicaram que a SMet não foi associada com o prejuízo cognitivo nesta população. Outros estudos prospectivos são necessários para melhor investigar a influência de idosos bem compensados nos componentes da SMet no desempenho cognitivo ao longo do tempo.

ABSTRACT Chronic degenerative conditions are very common in the elderly. According to medical literature, there is a correlation between cognitive impairment among elders and arterial hypertension/hyperglycemia which in turn are common diseases among the elderly population worldwide. Nonetheless, data on the association between cognitive impairment and Metabolic Syndrome (MetS) remains controversial. Objective: To compare the cognitive status of Brazilian elderly outpatients with and without MetS. Methods: A cross-sectional case-control study with 49 subjects (25 MetS and 24 controls) who underwent a global geriatric and neuropsychological assessment was carried out. The scores for cognitive abilities (sustained attention, alternating attention, immediate memory, working memory, memory - immediate recall, memory - delayed recall, memory - recognition, executive function, ideomotor praxis, constructive praxis, naming ability, verbal fluency) were compared with the data for the normal population and differences between case and control groups were analyzed using Student's t-test or the Mann-Whitney test. Results: Forty-five patients (91.8%) were female, with a mean age of 73.9±5.9 years, and 3.0±1.0 years of schooling. A significant difference (p<0.01) was found between case and control groups regarding the MetS components. For cognitive abilities, no statistically significant difference was detected between the groups and all subjects presented low cognitive scores. Conclusion: The results obtained in the present study showed that MetS was not associated with cognitive impairment in this population. Further prospective studies are necessary to investigate the influence of well-controlled MetS on cognitive performance among elders.

OBJETIVO: Avaliar a sensibilidade e a especificidade diagnósticas, e a concordância da Escala de Avaliação de Demência, com diagnóstico clínico de comprometimento cognitivo, e compará-las com as do Miniexame do Estado Mental. MÉTODOS: Oitenta e seis idosos de uma instituição de longa permanência foram convidados a participar do estudo e, destes, 58 concordaram em fazê-lo. A avaliação continha Miniexame do Estado Mental e Escala de Avaliação de Demência. O diagnóstico clínico de comprometimento cognitivo foi realizado por especialistas que utilizaram os critérios do DSM-IV. Escores da Escala de Avaliação de Demência e do Miniexame do Estado Mental foram correlacionados e suas sensibilidade e especificidade, obtidas. RESULTADOS: Vinte e dois (37,9%) idosos tinham comprometimento cognitivo (8,6% apresentaram comprometimento cognitivo leve e 29,3% demência). O Miniexame do Estado Mental e a Escala de Avaliação de Demência classificaram 31% e 55,2% como apresentando comprometimento cognitivo. Os escores da Escala de Avaliação de Demência e do Miniexame do Estado Mental tiveram uma forte correlação. A Escala de Avaliação de Demência teve uma sensibilidade maior do que o Miniexame do Estado Mental (86,4% versus 61,9%) e a especificidade foi menor (63,9% versus 86,5%). A concordância diagnóstica da Escala de Avaliação de Demência e do Miniexame do Estado Mental com a o diagnóstico clínico foi similar. CONCLUSÃO: A Escala de Avaliação de Demência mostrou uma sensibilidade maior na detecção de comprometimento cognitivo na população estudada e poderia ser um instrumento útil para aplicação em instituições de longa permanência.

OBJECTIVE: To evaluate the diagnostic sensitivity, specificity, and agreement of the Dementia Rating Scale with clinical diagnosis of cognitive impairment and to compare its psychometric measures with those from Mini Mental State Examination. METHODS: Eighty-six elders from a long-term care institution were invited to participate in a study, and fifty-eight agreed to participate. The global health assessment protocol applied to these elders contained Mini Mental State Examination and Dementia Rating Scale. Clinical diagnose of cognitive impairment was performed by experts using the DSM-IV criteria. Dementia Rating Scale score was correlated to the Mini Mental State Examination. Sensitivity and specificity of the Dementia Rating Scale and the Mini Mental State Examination were calculated. RESULTS: Twenty-two (37.9%) elders had cognitive impairment (8.6% presented with mental cognitive impairment and 29.3% dementia). The Mini Mental State Examination and the Dementia Rating Scale classified 31% and 55.2% as presenting with cognitively impaired. Dementia Rating Scale and the Mini Mental State Examination scores presented a strong correlation. Dementia Rating Scale had a higher sensitivity than Mini Mental State Examination (86.4% versus 61.9%). Dementia Rating Scale presented lower diagnostic specificity than Mini Mental State Examination (63.9% versus 86.5%). Considering Dementia Rating Scale and Mini Mental State Examination, the diagnostic agreement between them and the clinical diagnosis was similar. CONCLUSIONS: Dementia Rating Scale showed a high sensitivity to detect cognitive impairment in this population, and it could be a useful tool in these settings.

OBJECTIVE: To verify whether the serum levels of N-Terminal ProBNP fraction (ProBNP) allow us to identify with accuracy the clinical functional status of patients with heart failure (HF), because the clinical diagnosis of this syndrome is based basically on clinical data when the complementary tests have lower specificity. METHODS: Sixty-nine patients with a history of HF were studied. Their mean age of was 53.5 years and 78.3% were males. All underwent clinical and echocardiographic evaluations and a test to determine the serum dosage of ProBNP. According to clinical manifestation, patients were in the following functional classes (FC), 14% FC I, 40.6% FC II, 28.1% FC III, and 23.4% FC IV. The mean ejection fraction (EF) was 0.28. RESULTS: ProBNP did not differ according to age, sex, and cause of cardiopathy. No correlation existed between EF and the ProBNP serum level. ProBNP levels were significantly lower in patients in FC I than those in FC II (42 vs 326.7 pmol/L; P=0.0001), and in FC II than those in FC III (P=0.01). ProBNP levels did not differ statically between FC III and IV patients (888.1 vs 1082.8 pmol/L; P=0.25). ProBNP values greater than 100 pmol/L identify patients with decompensated HF with a sensitivity of 98%. CONCLUSION: ProBNP values over 100 pmol/L were indicative of HF, and patients with advanced HF had values over 270 pmol/L. A ProBNP dosage test was an excellent auxiliary in the clinical characterization of patients with HF.